-

Butterfly Network Strengthens Global Information Security Posture with ISO 27001, SOC-2 Type 2, C5 Germany, and NHS DSPT Accreditations

Milestone certifications mark Butterfly’s readiness to meet stringent data protection requirements globally.

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced it has achieved certification for ISO 27001, the world’s leading standard for information security management systems, published by the International Organization for Standardization (ISO) in partnership with the International Electrotechnical Commission (IEC). This globally recognized accreditation reinforces Butterfly’s commitment to maintaining the highest standards of cybersecurity and data protection requirements.

“Achieving ISO 27001 and additional international certifications reflects our uncompromising commitment to protecting data and earning the trust of hospitals, health systems, and customers around the world,” said Mike Tiemeyer, Chief Information Security Officer of Butterfly Network. “These certifications demonstrate that Butterfly meets rigorous, globally recognized standards and is a reliable partner for secure, enterprise-grade medical imaging. We have the added assurance of being assessed by A-LIGN, a leader in global security audit services, as our third-party assessment organization (3PAO).”

Butterfly has also successfully completed certification for SOC-2 Type 2, C5 Germany (Cloud Computing Compliance Criteria Catalogue), and The National Health Service (NHS) Data Security and Protection Toolkit (DSPT), further strengthening its global security posture across the US, UK, EU, and international markets.

Butterfly’s President, Chief Executive Officer and Chairman, Joseph DeVivo added, “Security is foundational to scaling Butterfly globally. With these internationally recognized certifications, we’re affirming not only our technological leadership in point-of-care imaging, but also our dedication to meeting the highest standards of trust, compliance, and protection.”

The latest certification strengthens Butterfly’s growing security foundation. In late 2024, the Company became one of the first (and the first in medical imaging) to earn GovRAMP SnapShot and expects full GovRAMP authorization later this year (along with the similar TX-RAMP certification). It also anticipates securing FedRAMP certification and is pursuing HITRUST CSF r2, a NIST 800-53 (Rev-5) framework that unifies standards like HIPAA and GDPR.

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.

Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.

Contacts

Media:
Liz Learned Snyder
Director, Comms & PR, Butterfly Network
media@butterflynetinc.com

Investors:
Steve Halper
Managing Director, LifeSci Advisors
shalper@lifesciadvisors.com

Butterfly Network, Inc.

NYSE:BFLY

Release Versions
$Cashtags

Contacts

Media:
Liz Learned Snyder
Director, Comms & PR, Butterfly Network
media@butterflynetinc.com

Investors:
Steve Halper
Managing Director, LifeSci Advisors
shalper@lifesciadvisors.com

Social Media Profiles
More News From Butterfly Network, Inc.

Butterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that its Butterfly iQ+/iQ3 and Compass AI™ ultrasound solution have achieved GovRAMP and TX-RAMP Authorizations. The certifications authorize the Company to sell cloud services to all state and local government agencies, including in the state of Texas. GovRA...

Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer...

Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth of at least 17% Year over Year

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “We enter 2026 with strong momentum and...
Back to Newsroom